NXTC FY 2025 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$36M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$58M

Net Income

-$56M

EPS (Diluted)

$-19.65

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$50M

Total Liabilities

$15M

Stockholders' Equity

$35M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$58M	-$60M	+3.6%
Net Income	-$56M	-$56M	-0.3%